Phase 1 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have been diagnosed with a pancreatic neuroendocrine tumor that has spread to other parts of the body or cannot be surgically removed, and is classified as grade 1, grade 2, or grade 3
- People who have at least one tumor or lesion measuring 1.5 cm or larger, as seen on a scan (such as a CT, MRI, PET, or ultrasound)
- People who are currently receiving treatment for their condition, as well as those who are not currently receiving any treatment
- People who are willing to allow previously collected tumor tissue samples (from another study, a tissue bank, or a clinical procedure) to be used for this research
- People who are willing to give written consent to take part and who are able to understand the nature of the study
Who may not be able to join:
- People who have received a liver-directed therapy that treated all of their known disease, and whose disease has not yet come back or progressed
- People who are unable to tolerate imaging scans, in the opinion of the treating doctor or investigator
- People who are pregnant or breastfeeding (a urine pregnancy test will be done before certain study procedures for people who could become pregnant)
- People who have a current medical condition, illness, or disorder that a doctor considers could put the participant at risk or affect their ability to take part in the study safely
- Children, prisoners, and people who are unable to give informed consent are not eligible to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Austin Pantel, MD, University of Pennsylvania
Phone: 215-573-6569
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
[18F]FTT SUV in PanNETS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.